{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:45:12Z","timestamp":1793295912000,"version":"4.5.0"},"reference-count":9,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:sec id=\"ab-ybr220006-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The direct and indirect implications of the COVID-19 pandemic have been associated with the mental health of children and adolescents, but it is uncertain whether these implications have been associated with changes in prescribing and diagnosis patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ybr220006-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine psychotropic medication use and rates of psychiatric disorders in Danish children, adolescents, and young adults during the COVID-19 pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ybr220006-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This population-based, descriptive register-based cohort study included all Danish individuals aged 5 to 24 years from January 1, 2017, until June 30, 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ybr220006-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Rates of filled prescriptions of psychotropic medications, including antipsychotics, anxiolytics, hypnotics, sedatives, antidepressants, and psychostimulants, and all inpatient and outpatient contacts with mental and behavioral disorders. Rates of new (incident) and total (prevalent) psychotropic medication use and psychiatric diagnoses were estimated. Rate ratios (RRs) were assessed between observed and expected numbers of incident psychotropic medication use or psychiatric diagnoses from March 2020 to June 30, 2022, comparing observed numbers with expected numbers predicted from the modeled prepandemic trend.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ybr220006-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study identified 108\u202f840 (58\u202f856 female individuals [54%]; median [IQR] age, 18 [14-22] years) incident psychotropic medication users. From March 2020 (first national lockdown) to June 2022, the rate of incident users of any psychotropic medication showed a relative increase of 18% (RR, 1.18; CI, 1.17-1.20) compared with expected numbers, which was primarily associated with an increase among those aged 12 to 17 years of 37% (RR, 1.37; 95% CI, 1.34-1.41). Similarly, there was an overall relative increase of incident psychiatric disorders of 5% (incidence rate, 1.05; CI, 1.04-1.07) (incident cases, 114\u202f048 [58\u202f708 female individuals (51%)]), which was associated with an increase in hyperkinetic disorders (RR, 1.13; CI, 1.09-1.18) and anxiety disorders (RR, 1.04; CI, 1.02-1.06). Prevalence patterns showed similar trends of an overall increase in psychotropic medication use and psychiatric disorders. One of 3 new users of an individual drug group had filled a prescription for a drug from another psychotropic medication group within the prior 6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ybr220006-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The results of this cohort study suggest that Danish youths experienced an increase in rates of psychotropic treatment and psychiatric disorder diagnoses during the COVID-19 pandemic, which was most pronounced among those aged 12 to 17 years. The increase was observed for children and adolescents with and without a psychiatric history within the last 5 years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2022.4165","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T11:01:11Z","timestamp":1671015671000},"page":"176","source":"Crossref","is-referenced-by-count":79,"title":["Psychotropic Medication Use and Psychiatric Disorders During the COVID-19 Pandemic Among Danish Children, Adolescents, and Young Adults"],"prefix":"10.1001","volume":"80","author":[{"given":"Mette","family":"Bliddal","sequence":"first","affiliation":[{"name":"Research Unit OPEN, Department of Clinical Research, University of Southern Denmark, Odense, Denmark"},{"name":"Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob Harbo","family":"Andersen","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Bj\u00f8dstrup","family":"Jensen","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Potteg\u00e5rd","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Munk-Olsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Kildegaard","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke","family":"Wesselhoeft","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark"},{"name":"Child and Adolescent Mental Health Odense, Mental Health Services in the Region of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"ybr220006r1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S2352-4642(21)00177-2","article-title":"Young people\u2019s mental health during the COVID-19 pandemic.","volume":"5","author":"Creswell","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"issue":"11","key":"ybr220006r2","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jamapediatrics.2021.2482","article-title":"Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis.","volume":"175","author":"Racine","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"4","key":"ybr220006r3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/jech-2021-216732","article-title":"Prescription of anxiolytics, sedatives, hypnotics and antidepressants in outpatient, universal care during the COVID-19 pandemic in Portugal: a nationwide, interrupted time-series approach.","volume":"76","author":"Estrela","year":"2022","journal-title":"J Epidemiol Community Health"},{"issue":"4","key":"ybr220006r4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/acps.v146.4","article-title":"Psychotropic medication use in pediatric population during COVID-19 pandemic.","volume":"146","author":"Kuitunen","year":"2022","journal-title":"Acta Psychiatr Scand"},{"key":"ybr220006r5","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291721004839","article-title":"Impact of COVID-19 pandemic and lockdowns on the consumption of anxiolytics, hypnotics and antidepressants according to age groups: a French nationwide study.","author":"Levaillant","journal-title":"Psychol Med"},{"issue":"3","key":"ybr220006r6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jamapediatrics.2021.5634","article-title":"Psychotropic drug use in children and adolescents before and during the COVID-19 pandemic.","volume":"176","author":"Leong","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"8","key":"ybr220006r7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10654-013-9873-0","article-title":"When the entire population is the sample: strengths and limitations in register-based epidemiology.","volume":"29","author":"Thygesen","year":"2014","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"ybr220006r8","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/ije\/dyt092","article-title":"Time series regression studies in environmental epidemiology.","volume":"42","author":"Bhaskaran","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"7","key":"ybr220006r9","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.3390\/ijerph18073432","article-title":"Mental health of children and adolescents amidst COVID-19 and past pandemics: a rapid systematic review.","volume":"18","author":"Meherali","year":"2021","journal-title":"Int J Environ Res Public Health"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2799490\/jamapsychiatry_bliddal_2022_br_220006_1675180175.66213.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T11:32:47Z","timestamp":1675251167000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2799490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.4165","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,1]]}}}